Yasuo Uchida

Dr. Yasuo Uchida

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2011 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
YUYasuo Uchida
Yasuo Uchida
SOSumio Ohtsuki
Sumio Ohtsuki
YKYuki Katsukura
Yuki Katsukura
CIChiemi Ikeda
Chiemi Ikeda
TSTakashi Suzuki
Takashi Suzuki
TTTetsuya Terasaki
Tetsuya Terasaki

25 January 2008 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
JKJunichi Kamiie
Junichi Kamiie
SOSumio Ohtsuki
Sumio Ohtsuki
RIRyo Iwase
Ryo Iwase
KOKen Ohmine
Ken Ohmine
YKYuki Katsukura
Yuki Katsukura
TTTetsuya Terasaki
Tetsuya Terasaki

27 June 2011 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
RSramzi shawahna
ramzi shawahna
YUYasuo Uchida
Yasuo Uchida
XDXavier DECLEVES
Xavier DECLEVES
SOSumio Ohtsuki
Sumio Ohtsuki
SYSalah Yousif
Salah Yousif
JSJean-Michel Scherrmann
Jean-Michel Scherrmann

11 December 2012 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
SOSumio Ohtsuki
Sumio Ohtsuki
CIChiemi Ikeda
Chiemi Ikeda
YUYasuo Uchida
Yasuo Uchida
YSYumi Sakamoto
Yumi Sakamoto
FMFlorence Miller
Florence Miller
TTTetsuya Terasaki
Tetsuya Terasaki

1 September 2011 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
KIKatsuaki Ito
Katsuaki Ito
YUYasuo Uchida
Yasuo Uchida
SOSumio Ohtsuki
Sumio Ohtsuki
SASanshiro Aizawa
Sanshiro Aizawa
HKHirotaka Kawakami
Hirotaka Kawakami
TTTetsuya Terasaki
Tetsuya Terasaki

8 June 2013 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
YUYasuo Uchida
Yasuo Uchida
MTMasanori Tachikawa
Masanori Tachikawa
WOWataru Obuchi
Wataru Obuchi
YHYutaro Hoshi
Yutaro Hoshi
YTYusuke Tomioka
Yusuke Tomioka
TTTetsuya Terasaki
Tetsuya Terasaki
Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the identified proteins must also be elucidated, but this is complicated by the inability of conventional proteomic methods to yield quantitative information for protein expression. Thus, a variety of biological systems remain “black boxes”. Quantitative targeted absolute proteomics (QTAP) enables the determination of absolute expression levels (mol) of any target protein, including low-abundance functional proteins, such as transporters and receptors. Therefore, QTAP will be useful for understanding the activities and roles of individual proteins and their differences, including normal/disease, human/animal, or in vitro/in vivo. Here, we describe the study protocols and precautions for QTAP experiments including in silico target peptide selection, determination of peptide concentration by amino acid analysis, setup of selected/multiple reaction monitoring (SRM/MRM) analysis in liquid chromatography–tandem mass spectrometry, preparation of protein samples (brain capillaries and plasma membrane fractions) followed by the preparation of peptide samples, simultaneous absolute quantification of target proteins by SRM/MRM analysis, data analysis, and troubleshooting. An application of QTAP in biological sciences was introduced that utilizes data from inter-strain differences in the protein expression levels of transporters, receptors, tight junction proteins and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice. Among 18 molecules, 13 (abcb1a/mdr1a/P-gp, abcc4/mrp4, abcg2/bcrp, slc2a1/glut1, slc7a5/lat1, slc16a1/mct1, slc22a8/oat3, insr, lrp1, tfr1, claudin-5, Na+/K+-ATPase, and γ-gtp) were detected in the isolated brain capillaries, and their protein expression levels were within a range of 0.637-101 fmol/μg protein. The largest difference in the levels between the three strains was 2.2-fold for 13 molecules, although bcrp and mct1 displayed statistically significant differences between C57BL/6J and the other strain(s). Highly sensitive simultaneous absolute quantification achieved by QTAP will increase the usefulness of proteomics in biological sciences and is expected to advance the new research field of pharmacoproteomics (PPx).